Hollema HH - Search Results

1

Cell biological markers of drug resistance in ovarian carcinoma.

van der Zee AG, Hollema HH, de Bruijn HW, Willemse PH, Boonstra H, Mulder NH, Aalders JG, de Vries EG. van der Zee AG, et al. Among authors: hollema hh. Gynecol Oncol. 1995 Aug;58(2):165-78. doi: 10.1006/gyno.1995.1205. Gynecol Oncol. 1995. PMID: 7622101 Review.

2

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.

van der Zee AG, van Ommen B, Meijer C, Hollema H, van Bladeren PJ, de Vries EG. van der Zee AG, et al. Br J Cancer. 1992 Nov;66(5):930-6. doi: 10.1038/bjc.1992.388. Br J Cancer. 1992. PMID: 1419639 Free PMC article.

3

Cisplatin in gynecologic carcinosarcoma.

Willemse PH, Bouma J, Hollema H. Willemse PH, et al. J Clin Oncol. 1992 Aug;10(8):1365-6. doi: 10.1200/JCO.1992.10.8.1365. J Clin Oncol. 1992. PMID: 1634928 No abstract available.

4

P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.

van der Zee AG, Hollema H, de Jong S, Boonstra H, Gouw A, Willemse PH, Zijlstra JG, de Vries EG. van der Zee AG, et al. Cancer Res. 1991 Nov 1;51(21):5915-20. Cancer Res. 1991. PMID: 1682037

5

Radical surgery compared with intracavitary cesium followed by radical surgery in cervical carcinoma stage IB. Analysis of patients less than or equal to 45 years of age with small tumors with regard to treatment results and ovarian preservation in the primary surgery group.

Tinga DJ, Bouma J, Hollema H, Aalders JG. Tinga DJ, et al. Acta Obstet Gynecol Scand. 1990;69(3):239-44. doi: 10.3109/00016349009028687. Acta Obstet Gynecol Scand. 1990. PMID: 2220346

6

Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations.

Duk JM, de Bruijn HW, Groenier KH, Hollema H, ten Hoor KA, Krans M, Aalders JG. Duk JM, et al. Gynecol Oncol. 1990 Nov;39(2):186-94. doi: 10.1016/0090-8258(90)90430-s. Gynecol Oncol. 1990. PMID: 2227594

7

Karyotyping and DNA flow cytometry of metastatic ovarian yolk sac tumor.

Vos A, Oosterhuis JW, de Jong B, Castedo SM, Hollema H, Buist J, Aalders JG. Vos A, et al. Cancer Genet Cytogenet. 1990 Feb;44(2):223-8. doi: 10.1016/0165-4608(90)90051-b. Cancer Genet Cytogenet. 1990. PMID: 2297683

8

Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin.

Duk JM, van Voorst Vader PC, ten Hoor KA, Hollema H, Doeglas HM, de Bruijn HW. Duk JM, et al. Cancer. 1989 Oct 15;64(8):1652-6. doi: 10.1002/1097-0142(19891015)64:8<1652::aid-cncr2820640816>3.0.co;2-m. Cancer. 1989. PMID: 2790678

9

Is there a role for simple hysterectomy after irradiation for bulky cervical carcinoma?

Tinga DJ, Bouma J, Hollema H, Oosterhuis JW, Timmer PR, Aalders JG. Tinga DJ, et al. Eur J Gynaecol Oncol. 1988;9(3):191-5. Eur J Gynaecol Oncol. 1988. PMID: 3391189

10

TNO-6-induced acute renal failure. A case report.

Offerman JJ, Hollema H, Elema JD, Schraffordt Koops H, de Vries EG. Offerman JJ, et al. Cancer. 1985 Oct 1;56(7):1511-4. doi: 10.1002/1097-0142(19851001)56:7<1511::aid-cncr2820560706>3.0.co;2-l. Cancer. 1985. PMID: 4027887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters